These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11403176)

  • 1. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
    Mateos JJ; Setoain X; Ferre J; Rovirosa A; Navalpotro B; Martin F; Ortega M; Lomeña F; Fuster D; Pavia J; Pons F
    Nucl Med Commun; 2001 Jun; 22(6):651-6. PubMed ID: 11403176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of pilocarpine in the prevention of xerostomia in patients with head and neck cancer treated with radiotherapy. Assessment with gammagraphy and salivary flow].
    Fuertes Cabero S; Setoain Perego X; Rovirosa Casino A; Mateos Fernández JJ; Fuster Pelfort D; Ferre Jorge J; Navalpotro Yagüe V; Paredes Barranco P; Ortín Pérez J; Muxí Pradas A; Pons Pons F
    Rev Esp Med Nucl; 2004; 23(4):259-66. PubMed ID: 15207210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
    Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
    Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of oral pilocarpine in radiation-induced xerostomia in oropharyngeal carcinoma patients.
    Kaur H; Singh Banipal RP; Singh H; Sonik YA; Sandhu SK
    J Cancer Res Ther; 2023; 19(3):788-792. PubMed ID: 37470612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilocarpine in the prevention of postirradiation xerostomia.
    Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
    Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
    Cooper RA; Cowan RA; Owens SE; Jeans SP; Roberts JK; Hillel PG; Slevin NJ; Allan E; Gupta NK; Collins CD
    Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
    Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
    Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilocarpine treatment of xerostomia in head and neck patients.
    Leek H; Albertsson M
    Micron; 2002; 33(2):153-5. PubMed ID: 11567884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
    Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
    Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
    Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history and prevention of radiation injury.
    O'Connell AC
    Adv Dent Res; 2000 Dec; 14():57-61. PubMed ID: 11842925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic pilocarpine for treatment of xerostomia.
    Berk L
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1333-40. PubMed ID: 18798702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
    Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
    Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
    Davies AN; Thompson J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003782. PubMed ID: 26436597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.